NANOGEN, INC.

CARDIOQUANT

diagnostic reagents for use with medical diagnostic devices and apparatus, namely, cardiac immunoassay compositions and controls, and calibrators used to insure the accuracy and precision of instruments and for use with kits used to determine the presence or amount of diagnostic components in body fluids;

CMYO

Pharmaceutical products, namely medical diagnostic kits comprising a device for the detection of blood-borne analytes useful to diagnose a cardiac condition;

ELECTROCAPTURE

Electronic apparatuses for chemically analyzing biological material;ELECTRONIC CAPTURE;

MAKING THE REVOLUTIONARY ROUTINE

Medical diagnostic reagents and assay kits consisting primarily of medical diagnostic reagents and specimen receptors for bacterial identification, tissue typing and testing of human physiological conditions;

NANOTRONICS

micro-circuit assemblies, namely, memory arrays, logic circuits and micro-processors, and combinations thereof;

NGEN

The mark consists of the letter N followed by a double helix and then the letters gen.;Clinical medical reagents; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; nucleic acid sequences and chemical reagents for medical and veterinary purposes; reagents and media for medical and veterinary diagnostic purposes;Color is not claimed as a feature of the mark.;Assays and reagents for use in genetic research; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; diagnostic preparations or reagents for scientific or research use; reagents for scientific or medical research use;